NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT03693612 2024-08-28GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsGlaxoSmithKlinePhase 1/2 Completed26 enrolled 47 charts
NCT05094804 2023-11-02A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Unknown172 enrolled
NCT02126969 2023-03-13A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHNUniversity of KentuckyPhase 2 Completed45 enrolled 13 charts
NCT00591149 2017-06-14Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerUniversity of Kansas Medical CenterPhase 2 Terminated16 enrolled 5 charts
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled
NCT00273546 2009-04-29Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerSanofiPhase 3 Completed500 enrolled